BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 38167622)

  • 1. Immunohistochemical FAP Expression Reflects
    Spektor AM; Gutjahr E; Lang M; Glatting FM; Hackert T; Pausch T; Tjaden C; Schreckenberger M; Haberkorn U; Röhrich M
    J Nucl Med; 2024 Jan; 65(1):52-58. PubMed ID: 38167622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Static and Dynamic
    Lang M; Spektor AM; Hielscher T; Hoppner J; Glatting FM; Bicu F; Hackert T; Heger U; Pausch T; Gutjahr E; Rathke H; Giesel FL; Kratochwil C; Tjaden C; Haberkorn U; Röhrich M
    J Nucl Med; 2023 Feb; 64(2):244-251. PubMed ID: 35906094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of preoperative [
    Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Huo L; Li X
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1780-1791. PubMed ID: 36695823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased SOX9 Expression in Premalignant and Malignant Pancreatic Neoplasms.
    Gnerlich JL; Ding X; Joyce C; Turner K; Johnson CD; Chen H; Abood GJ; Pappas SG; Aranha GV
    Ann Surg Oncol; 2019 Feb; 26(2):628-634. PubMed ID: 30357576
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Kessler L; Hirmas N; Pabst KM; Hamacher R; Ferdinandus J; Schaarschmidt BM; Milosevic A; Nader M; Umutlu L; Uhl W; Reinacher-Schick A; Lugnier C; Witte D; Niedergethmann M; Herrmann K; Fendler WP; Siveke JT
    J Nucl Med; 2023 Dec; 64(12):1910-1917. PubMed ID: 37973185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of
    Röhrich M; Naumann P; Giesel FL; Choyke PL; Staudinger F; Wefers A; Liew DP; Kratochwil C; Rathke H; Liermann J; Herfarth K; Jäger D; Debus J; Haberkorn U; Lang M; Koerber SA
    J Nucl Med; 2021 Jun; 62(6):779-786. PubMed ID: 33097632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception.
    Hernandez S; Parra ER; Uraoka N; Tang X; Shen Y; Qiao W; Jiang M; Zhang S; Mino B; Lu W; Pandurengan R; Haymaker C; Affolter K; Scaife CL; Yip-Schneider M; Schmidt CM; Firpo MA; Mulvihill SJ; Koay EJ; Wang H; Wistuba II; Maitra A; Solis LM; Sen S
    Clin Cancer Res; 2022 May; 28(9):1938-1947. PubMed ID: 35491652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A rare case of intraductal tumor of the pancreas in which an intraductal tubulopapillary neoplasm was mixed with a widely spreading gastric-type intraductal papillary-mucinous neoplasm].
    Wakabayashi T; Shirota Y; Takeda Y; Hodo Y; Ueda Y
    Nihon Shokakibyo Gakkai Zasshi; 2024; 121(5):415-424. PubMed ID: 38735750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
    Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
    Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
    Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.
    Fritz S; Klauss M; Bergmann F; Strobel O; Schneider L; Werner J; Hackert T; Büchler MW
    Ann Surg; 2014 Nov; 260(5):848-55; discussion 855-6. PubMed ID: 25379856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Zhu Z; Cheng K; Yun Z; Zhang X; Hu X; Liu J; Wang F; Fu Z; Yue J
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3425-3438. PubMed ID: 37328622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of early and late
    Hoppner J; van Genabith L; Hielscher T; Heger U; Sperling L; Colbatzky T; Gutjahr E; Lang M; Pausch T; Spektor AM; Glatting FM; Liermann J; Hackert T; Kratochwil C; Giesel FL; Haberkorn U; Röhrich M
    Sci Rep; 2023 Oct; 13(1):17848. PubMed ID: 37857656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis.
    Muraki T; Jang KT; Reid MD; Pehlivanoglu B; Memis B; Basturk O; Mittal P; Kooby D; Maithel SK; Sarmiento JM; Christians K; Tsai S; Evans D; Adsay V
    Mod Pathol; 2022 Jan; 35(1):96-105. PubMed ID: 34518632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the clinical value of baseline [
    Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Li X; Huo L
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4036-4050. PubMed ID: 37493664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules.
    Takanami K; Hiraide T; Tsuda M; Nakamura Y; Kaneta T; Takase K; Fukuda H; Takahashi S
    Ann Nucl Med; 2011 Aug; 25(7):501-10. PubMed ID: 21537945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative imaging to evaluate malignant potential of IPMNs.
    Hanania AN; Bantis LE; Feng Z; Wang H; Tamm EP; Katz MH; Maitra A; Koay EJ
    Oncotarget; 2016 Dec; 7(52):85776-85784. PubMed ID: 27588410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of positron emission tomography (PET)/contrast-enhanced computed tomography (CE-CT) in discriminating between malignant and benign intraductal papillary mucinous neoplasms (IPMNs).
    Ohta K; Tanada M; Sugawara Y; Teramoto N; Iguchi H
    Pancreatology; 2017; 17(6):911-919. PubMed ID: 29033011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.
    Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K
    Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.